Tobira Therapeutics Completes Patient Recruitment for CENTAUR Phase 2b Study of Cenicriviroc in NASH with Liver Fibrosis
June 8, 2015Tobira completes recruitment for the Phase 2b CENTAUR clinical trial evaluating the treatment effects of CVC in patients with high-risk non-alcoholic steatohepatitis and liver fibrosis. Results of the one-year primary endpoint are expected in mid-2016.
More »
Tandem Diabetes Care Announces t:simulator™ App Now Available for Android Devices
June 8, 2015Tandem Diabetes Care's t:simulator™ App is now available for devices using the Android operating system, which mirrors the same steps used on a t:slim Pump for the most commonly used insulin pump tasks.
More »
Celator(R) Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) at High-Risk of Treatment-Related Mortality
June 8, 2015Celator's investigator-initiated clinical study evaluating CPX-351 Liposome Injection, for treating patients with untreated high-risk MDS and AML, has met the efficacy and safety criteria to expand the current cohort from 20 to 30 patients.
More »